Concepedia

Prenatal exposure to HMG-CoA reductase inhibitors: Effects on fetal and neonatal outcomes

Nobuko Taguchi, Evelyn Rubin, Akiko Hosokawa, Jacquelyn Choi, Angela Yating Ying, Myla E. Moretti, Gideon Koren, Shinya Ito

Reproductive Toxicology · 2008 · 142 citations · 10 references

DOI

Concepts

References

10

Unintended Pregnancy in the United States

Stanley K. Henshaw · Family Planning Perspectives · 1998 · 1.4K citations

, , +16

The Teratogenicity of Anticonvulsant Drugs

Lewis B. Holmes, Elizabeth A. Harvey, Brent A. Coull et al. · New England Journal of Medicine · 2001 · 659 citations · Full text

, , +17

Mechanistic and epidemiologic considerations in the evaluation of adverse birth outcomes following gestational exposure to statins

Robin J. Edison, Maximilian Muenke · American Journal of Medical Genetics Part A · 2004 · 206 citations

, , +17

Pregnancy outcomes after maternal exposure to simvastatin and lovastatin

Pia S. Pollack, Kristine E. Shields, Diane M. Burnett et al. · Birth Defects Research Part A Clinical and Molecular Teratology · 2005 · 107 citations

, , +17

Mevalonate supplementation in pregnant rats suppresses the teratogenicity of mevinolinic acid, an inhibitor of 3‐hydroxy‐3‐methylglutaryl‐coenzyme a reductase

David H. Minsker, J. S. Macdonald, Richard T. Robertson et al. · Teratology · 1983 · 103 citations

, , +14